Can Molecular Biomarkers Help Reduce the Overtreatment of DCIS?

Hahn, Ezra; Rodin, Danielle; Sutradhar, Rinku; Nofech-Mozes, Sharon; Trebinjac, Sabina; Paszat, Lawrence Frank; Rakovitch, Eileen

Hahn, Ezra; Rodin, Danielle; Sutradhar, Rinku; Nofech-Mozes, Sharon; Trebinjac, Sabina; Paszat, Lawrence Frank; Rakovitch, Eileen.

Affiliation

Hahn E; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON M5G 2C4, Canada.
Rodin D; Department of Radiation Oncology, University of Toronto, Toronto, ON M5T 1P5, Canada.
Sutradhar R; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON M5G 2C4, Canada.
Nofech-Mozes S; Department of Radiation Oncology, University of Toronto, Toronto, ON M5T 1P5, Canada.
Trebinjac S; Institute for Clinical Evaluative Sciences, Toronto, ON M4N 3M5, Canada.
Paszat LF; Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5T 3M7, Canada.
Rakovitch E; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.

Curr Oncol ; 30(6): 5795-5806, 2023 06 13.

Article de En | MEDLINE | ID: mdl-37366916

Sujet(s)
Mots clés

DCIS; biomarkers; ductal carcinoma in situ

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Carcinome intracanalaire non infiltrant Type d'étude: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limites: Female / Humans Langue: En Journal: Curr Oncol Année: 2023 Type de document: Article Pays d'affiliation: Canada Pays de publication: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google